Parmax Pharma gets nod for plant expansion for manufacturing of API products

20 Jun 2018 Evaluate

Parmax Pharma has received an approval for expansion of plant for manufacturing of API products under Goods Manufacturing Practices. The Board of Directors at their meeting held on June 17, 2018, approved the same.

Parmax Pharma deals in all kinds of drug and drugs used in pharmaceutical, medicinal biological immunological, contraceptive and therapeutim preparations, substance materials and articles of all classes and description.

Parmax Pharma Share Price

29.90 1.38 (4.84%)
10-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1813.00
Dr. Reddys Lab 1313.90
Cipla 1333.10
Zydus Lifesciences 922.90
Lupin 2340.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×